2020年12月最新中科院JCR期刊分区数据【基础版、升级版（试行）】均已更新，欢迎查询使用！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 期刊名字 | ENDOCRINE-RELATED CANCER ENDOCR-RELAT CANCER 7.4 我要评分
声誉 8.8 影响力 6.5 速度 7.0 | |||||||||||||||||||||||||||||
| 期刊ISSN | 1351-0088 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||
| 2019-2020自引率 | 3.60%登录查看自引率趋势图 | |||||||||||||||||||||||||||||
| h-index | 119 | |||||||||||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||||||||||
| 期刊官方网站 | http://erc.endocrinology-journals.org/ | |||||||||||||||||||||||||||||
| 期刊投稿网址 | http://www.endocrinology-journals.org/site/misc/submit-online.xhtml | |||||||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||||||
| 通讯方式 | BIOSCIENTIFICA LTD, EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL, ENGLAND, BS324JT | |||||||||||||||||||||||||||||
| 出版商 | BioScientifica Ltd. | |||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-内分泌学与代谢 | |||||||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||
| 出版周期 | Quarterly | |||||||||||||||||||||||||||||
| 出版年份 | 1994 | |||||||||||||||||||||||||||||
| 年文章数 | 112登录查看年文章数趋势图 | |||||||||||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 （ 2021年1月发布版） | 不在预警名单中 | |||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月最新基础版） | 登录查看中科院JCR分区趋势图
| |||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月最新升级版） |
| |||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年1月旧的升级版） |
| |||||||||||||||||||||||||||||
| SCI期刊coverage | Science Citation Index Science Citation Index Expanded | |||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1351-0088%5BISSN%5D | |||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 较慢,6-12周 | |||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 一般 | |||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||
|
|
| |
| 登录查看自引率趋势图 |
| 登录查看中科院JCR分区趋势图 |
| 登录查看年文章数趋势图 |
| 中国学者近期发表的论文 | |
| 1. | Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ. Author: Xekouki P1,2, Lodge EJ1,3, Matschke J4, Santambrogio A1,5, Apps JR6,7, Sharif A8, Jacques TS6,7, Aylwin S2, Prevot V8, Li R9, Flitsch J10, Bornstein SR3,5, Theodoropoulou M11, Andoniadou CL1,5. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):215-225. doi: 10.1530/ERC-18-0330. PubMed DOI |
| 2. | Antitumor effects of anlotinib in thyroid cancer. Author: Ruan X1, Shi X2, Dong Q2, Yu Y1, Hou X1, Song X2, Wei X3, Chen L2, Gao M1. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):153-164. doi: 10.1530/ERC-17-0558. PubMed DOI |
| 3. | KLF14 potentiates oxidative adaptation via modulating HO-1 signaling in castrate-resistant prostate cancer. Author: Luo XH1, Liu JZ1, Wang B1, Men QL1, Ju YQ1, Yin FY1, Zheng C1, Li W2. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):181-195. doi: 10.1530/ERC-18-0383. PubMed DOI |
| 4. | Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer. Author: Guan W1, Hu J1,2,3, Yang L4, Tan P4, Tang Z4, West BL5, Bollag G5, Xu H1, Wu L3,6,7,8,9. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):131-140. doi: 10.1530/ERC-18-0284. PubMed DOI |
| 5. | ATM deficiency promotes progression of CRPC by enhancing Warburg effect. Author: Xu L1,2, Ma E3, Zeng T2,4, Zhao R5, Tao Y2, Chen X2, Groth J2, Liang C1, Hu H2,6, Huang J2,6,7. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):59-71. doi: 10.1530/ERC-18-0196. PubMed DOI |
| 6. | KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC. Author: Wei X1, Cai S2,3, Boohaker RJ2, Fried J2, Li Y4, Hu L5, Pan Y5, Cheng R5, Zhang S1, Tian Y3, Gao M5, Xu B2,6. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):141-151. doi: 10.1530/ERC-18-0193. PubMed DOI |
| 7. | SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer. Author: Han F1, Liu WB2, Li JJ3, Zhang MQ4, Yang JT5, Zhang X6, Hao XL7, Yin L8, Mao CY9, Jiang X10, Cao J11, Liu JY12. Journal: Endocr Relat Cancer. 2019 Jan 1. pii: ERC-18-0529.R1. doi: 10.1530/ERC-18-0529. [Epub ahead of print] PubMed DOI |
| 8. | Roles of the HOXA10 gene during castrate-resistant prostate cancer progression. Author: Long Z1,2, Li Y2, Gan Y2,3, Zhao D4,5,6, Wang G4,5,6, Xie N2, Lovnicki JM2, Fazli L2, Cao Q7, Chen K4,5,6, Dong X2. Journal: Endocr Relat Cancer. 2019 Mar 1;26(3):279-292. doi: 10.1530/ERC-18-0465. PubMed DOI |
| 9. | Targeting autophagy in thyroid cancers. Author: Wei WJ1, Hardin H2, Luo QY3. Journal: Endocr Relat Cancer. 2019 Jan 1. pii: ERC-18-0502.R1. doi: 10.1530/ERC-18-0502. [Epub ahead of print] PubMed DOI |
| 10. | Exosomes increased angiogenesis in papillary thyroid cancer microenvironment. Author: Wu F1, Li F2, Lin X3, Xu F4, Cui R5, Zhong J6, Zhu T7, Shan SK8, Liao XB9, Yuan L10, Mo Z11. Journal: Endocr Relat Cancer. 2019 Mar 1. pii: ERC-19-0008.R1. doi: 10.1530/ERC-19-0008. [Epub ahead of print] PubMed DOI |
|
|
| 首页 上一页 1 下一页 尾页 (去 | |
| 以上SCI期刊相关数据和信息来源于网络，仅供参考。 | |
同领域作者分享投稿经验：共1条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 人才招聘
© 2010-2021 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公安备案号：31010402006960
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
